|
US4838925A
(en)
|
1986-04-25 |
1989-06-13 |
E. I. Du Pont De Nemours And Company |
Heterocyclic acyl sulfonamides
|
|
JP3763997B2
(ja)
|
1999-05-13 |
2006-04-05 |
富士写真フイルム株式会社 |
感熱記録材料
|
|
JP4331823B2
(ja)
|
1999-05-21 |
2009-09-16 |
富士フイルム株式会社 |
ピロロ［１，２−ａ］−１，３，５−トリアジン−４−オン系化合物
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
JP4070966B2
(ja)
|
2001-06-28 |
2008-04-02 |
株式会社カネボウ化粧品 |
新規ガラクトシルセラミド類縁体及び用途
|
|
ATE307812T1
(de)
|
2001-10-22 |
2005-11-15 |
Pfizer |
Imidazopyridinverbindungen als 5-ht4- rezeptormodulatoren
|
|
US20050096322A1
(en)
|
2002-03-01 |
2005-05-05 |
Susumu Igarashi |
Nitrogen-containing heterocyclic compound
|
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
|
MXPA05003065A
(es)
|
2002-09-20 |
2005-05-27 |
Pfizer |
Compuestos de piperidinil-imidazopiridina n-sustituidos como moduladores del receptor 5-ht4.
|
|
US7550470B2
(en)
|
2002-12-11 |
2009-06-23 |
Merck & Co. Inc. |
Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
|
|
JP2004277337A
(ja)
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
MXPA05011270A
(es)
|
2003-04-21 |
2006-01-24 |
Pfizer |
Compuestos de imidazopiridina que tienen actividad agonista del receptor 5-ht4 y actividad antagonista del receptor 5-ht3.
|
|
EP1682504B1
(en)
|
2003-11-12 |
2012-12-26 |
Amicus Therapeutics Inc. |
Hydroxy piperidine derivatives to treat gaucher disease
|
|
GB0329214D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
AU2005212096B2
(en)
|
2004-02-18 |
2010-12-16 |
Msd K.K. |
Nitrogenous fused heteroaromatic ring derivative
|
|
NZ551424A
(en)
|
2004-05-14 |
2009-10-30 |
Childrenaes Cancer Inst Austra |
Small molecule inhibitors for MRP1 and other multidrug transporters
|
|
HRP20080070T3
(en)
|
2004-06-21 |
2008-05-31 |
F. Hoffmann - La Roche Ag |
Pyrrazolo-pyrimidine derivatives
|
|
JP2008508337A
(ja)
|
2004-08-02 |
2008-03-21 |
シュバルツ ファルマ アクチェンゲゼルシャフト |
インドリジンカルボキサミド並びにそのアザ及びジアザ誘導体
|
|
DE102004049363A1
(de)
|
2004-10-08 |
2006-04-13 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
WO2006078676A2
(en)
|
2005-01-19 |
2006-07-27 |
Merck & Co., Inc. |
Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
CN101115755B
(zh)
|
2005-02-11 |
2013-01-16 |
弗·哈夫曼-拉罗切有限公司 |
作为mglur2拮抗剂的吡唑并-嘧啶衍生物
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
JPWO2006115168A1
(ja)
|
2005-04-21 |
2008-12-18 |
大日本住友製薬株式会社 |
Ｎ−置換フェニルアセトアミド誘導体およびそれを含有する医薬組成物
|
|
JP5079500B2
(ja)
|
2005-04-28 |
2012-11-21 |
協和発酵キリン株式会社 |
２−アミノキナゾリン誘導体
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
CN101316847A
(zh)
|
2005-10-06 |
2008-12-03 |
先灵公司 |
用作蛋白激酶抑制剂的吡唑并(1,5a)嘧啶化合物
|
|
CA2626789A1
(en)
|
2005-10-21 |
2007-04-26 |
Exelixis, Inc. |
Pyrimidinones as casein kinase ii (ck2) modulators
|
|
AU2006322187A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
|
|
TW200800997A
(en)
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
JP5303458B2
(ja)
|
2006-06-23 |
2013-10-02 |
アミークス セラピューティックス インコーポレイテッド |
β−グルコセレブロシダーゼの活性増強による神経学的疾患の治療方法
|
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
|
US7553846B2
(en)
|
2006-08-07 |
2009-06-30 |
Albany Molecular Research, Inc. |
2-alkylbenzoxazole carboxamides as 5-HT3 modulators
|
|
AU2007321923A1
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic matrix metalloprotease inhibitors
|
|
WO2008063671A2
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
US20080255153A1
(en)
|
2007-03-28 |
2008-10-16 |
Biovitrum Ab (Publ) |
New compounds
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
WO2008157575A1
(en)
|
2007-06-21 |
2008-12-24 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
WO2009060835A1
(ja)
|
2007-11-05 |
2009-05-14 |
Kyoto University |
新規ユビキリン結合性小分子
|
|
EP2217601A1
(en)
|
2007-11-08 |
2010-08-18 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyridazines for use as protein kinase inhibitors
|
|
MX2010005950A
(es)
|
2007-11-28 |
2010-06-17 |
Schering Corp |
2-fluoropirazolo[1,5-a]pirimidinas como inhibidores de proteina quinasa.
|
|
WO2009100375A1
(en)
|
2008-02-06 |
2009-08-13 |
Bristol-Myers Squibb Company |
Substituted imidazopyridazines useful as kinase inhibitors
|
|
WO2009119088A1
(ja)
|
2008-03-25 |
2009-10-01 |
武田薬品工業株式会社 |
複素環化合物
|
|
EA021938B1
(ru)
|
2008-05-01 |
2015-10-30 |
Сертрис Фармасьютикалз, Инк. |
Хинолины и их аналоги в качестве модуляторов сиртуина
|
|
CN102245605B
(zh)
|
2008-10-14 |
2016-01-27 |
阿斯利康(瑞典)有限公司 |
用于治疗细菌感染的稠合、螺环杂芳族化合物
|
|
CN102271515B
(zh)
|
2008-10-31 |
2014-07-02 |
健泰科生物技术公司 |
吡唑并嘧啶jak抑制剂化合物和方法
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
PE20121148A1
(es)
|
2009-08-17 |
2012-09-07 |
Intellikine Llc |
Compuestos heterociclicos y usos de los mismos
|
|
JP5985473B2
(ja)
|
2010-07-13 |
2016-09-06 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ＩＲＡＫ４モジュレーターとしてのピラゾロ［１，５ａ］ピリミジン及びチエノ［３，２ｂ］ピリミジン誘導体
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
TW201217312A
(en)
|
2010-09-22 |
2012-05-01 |
Gruenenthal Gmbh |
Substituted benzamide compounds
|
|
WO2012075393A2
(en)
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
|
DK2649075T3
(en)
*
|
2010-12-08 |
2018-07-30 |
Us Health |
SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
WO2012129258A1
(en)
|
2011-03-22 |
2012-09-27 |
Merck Sharp & Dohme Corp. |
Amidopyrazole inhibitors of interleukin receptor-associated kinases
|
|
WO2012177997A1
(en)
|
2011-06-22 |
2012-12-27 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
CN103857657B
(zh)
|
2011-08-18 |
2016-04-20 |
日本新药株式会社 |
杂环衍生物及医药
|
|
CN104039784B
(zh)
|
2011-09-02 |
2017-08-22 |
拜耳知识产权有限责任公司 |
取代的增环嘧啶及其用途
|
|
WO2013059119A1
(en)
|
2011-10-17 |
2013-04-25 |
The Regents Of The University Of Michigan |
Glucosylceramide synthase inhibitors and therapeutic methods using the same
|
|
RU2014120166A
(ru)
|
2011-10-20 |
2015-11-27 |
ГЛЭКСОСМИТКЛАЙН ЭлЭлСи |
Замещенные бициклические аза-гетероциклы и их аналоги в качестве модуляторов сиртуина
|
|
EP2794592A1
(en)
|
2011-12-23 |
2014-10-29 |
Novartis AG |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
|
US9340549B2
(en)
|
2012-03-05 |
2016-05-17 |
Amgen Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
RU2014140739A
(ru)
|
2012-03-09 |
2016-04-27 |
Лексикон Фармасьютикалз, Инк. |
Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения
|
|
WO2013148333A1
(en)
|
2012-03-28 |
2013-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Salicylic acid derivatives useful as glucocerebrosidase activators
|
|
KR20150020228A
(ko)
|
2012-05-31 |
2015-02-25 |
에프. 호프만-라 로슈 아게 |
아미노퀴나졸린 및 피리도피리미딘 유도체
|
|
EP2865671B1
(en)
|
2012-06-22 |
2017-11-01 |
Sumitomo Chemical Company, Ltd |
Fused heterocyclic compound
|
|
WO2014025651A1
(en)
|
2012-08-06 |
2014-02-13 |
Amgen Inc. |
Chroman derivatives as trpm8 inhibitors
|
|
EA201590482A1
(ru)
|
2012-09-05 |
2015-07-30 |
Байер Кропсайенс Аг |
Применение замещенных 2-амидобензимидазолов, 2-амидобензоксазолов и 2-амидобензотиазолов или их солей в качестве биологически активных веществ против абиотического стресса растений
|
|
US9573954B2
(en)
|
2012-11-16 |
2017-02-21 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
WO2014085607A1
(en)
|
2012-11-29 |
2014-06-05 |
Karyopharm Therapeutics Inc. |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
|
|
SI2941432T1
(en)
|
2012-12-07 |
2018-07-31 |
Vertex Pharmaceuticals Incorporated |
2-AMINO-6-FLUORO-N- (5-FLUORO-4- (4- (4- (OXETHAN-3-YL) PIPERAZIN-1-CARBONYL) PIPERIDIN-1-YLIPRIDIN-3-YL) 1,5 ALFA) PYRIMIDINE-3-CARBOXAMIDE AS ATR KINAZE INHIBITOR
|
|
KR20140086002A
(ko)
|
2012-12-28 |
2014-07-08 |
한미약품 주식회사 |
Fms 키나아제 저해 활성을 갖는 피리다진 접합고리 유도체
|
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
EP2970266B1
(en)
|
2013-03-15 |
2018-01-31 |
Epizyme, Inc. |
1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
JPWO2015012328A1
(ja)
|
2013-07-24 |
2017-03-02 |
武田薬品工業株式会社 |
複素環化合物
|
|
EP3035921A1
(en)
|
2013-08-20 |
2016-06-29 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
|
TW201542550A
(zh)
|
2013-09-06 |
2015-11-16 |
Lexicon Pharmaceuticals Inc |
吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
|
|
AR097543A1
(es)
|
2013-09-06 |
2016-03-23 |
Lexicon Pharmaceuticals Inc |
COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
|
|
WO2015073267A1
(en)
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
ES2895490T3
(es)
|
2014-03-27 |
2022-02-21 |
Acad Medisch Ct |
Iminoazúcares N-(5-(bifen-4-ilmetiloxi)pentil)-sustituidos como inhibidores de glucosilceramida sintasa
|
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
|
HRP20240644T1
(hr)
|
2014-11-06 |
2024-08-02 |
Bial-R&D Investments, S.A. |
Supstituirani pirazolo(1,5-a)pirimidini i njihova uporaba u liječenju medicinskih poremećaja
|
|
AU2015342883B2
(en)
|
2014-11-06 |
2020-07-02 |
Bial - R&D Investments, S.A. |
Substituted pyrrolo(1,2-a)pyrimidines and their use in the treatment of medical disorders
|
|
WO2016073889A1
(en)
|
2014-11-06 |
2016-05-12 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
|
|
CN108290894A
(zh)
|
2015-07-01 |
2018-07-17 |
西北大学 |
被取代的4-甲基-吡咯并[1,2-a]嘧啶-8-甲酰胺类化合物及其调节葡糖脑苷脂酶活性的用途
|
|
JP2018525345A
(ja)
|
2015-07-01 |
2018-09-06 |
ノースウェスタン ユニバーシティ |
置換キナゾリン化合物及びグルコセレブロシダーゼ活性の調節のためのその使用
|
|
WO2017040877A1
(en)
|
2015-09-04 |
2017-03-09 |
Lysosomal Therapeutics Inc. |
Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
|
|
RS63359B1
(sr)
|
2015-11-06 |
2022-07-29 |
Incyte Corp |
Heterociklična jedinjenja kao inhibitori pi3k-gama
|
|
US10479793B2
(en)
|
2015-11-18 |
2019-11-19 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
|
|
EP3416967B1
(en)
|
2016-02-18 |
2022-02-09 |
F. Hoffmann-La Roche AG |
Therapeutic compounds, compositions and methods of use thereof
|
|
US11192892B2
(en)
|
2016-04-06 |
2021-12-07 |
Bial—R&D Investments, S.A. |
Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders
|
|
EP3440081A4
(en)
|
2016-04-06 |
2019-09-18 |
Lysosomal Therapeutics Inc. |
PYRROLO [1,2-A] PYRIMIDINYL-CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDER
|
|
CA3020305A1
(en)
|
2016-04-06 |
2017-10-12 |
Lysosomal Therapeutics Inc. |
Imidazo [1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
EP3452045A1
(en)
*
|
2016-05-04 |
2019-03-13 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
WO2017192929A1
(en)
|
2016-05-05 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED PYRROLO[1,2-α]TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
SG11201809693SA
(en)
|
2016-05-05 |
2018-11-29 |
Lysosomal Therapeutics Inc |
SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
EP3452455A4
(en)
|
2016-05-05 |
2019-11-13 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED IMDAZO [1,2-] PYRIDINES, SUBSTITUTED IMIDAZO [1,2-] PYRAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF ILLNESSES
|
|
JP2021506920A
(ja)
|
2017-12-21 |
2021-02-22 |
リソソーマル・セラピューティクス・インコーポレイテッドＬｙｓｏｓｏｍａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
結晶性の置換シクロヘキシルピラゾロ［１，５−ａ］ピリミジニルカルボキサミド化合物およびその治療的使用
|